Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.

@article{HerescoLevy1999EfficacyOH,
  title={Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.},
  author={Uriel Heresco-Levy and D. C. Javitt and Marina Ermilov and C Mordel and Gail S Silipo and Meir Lichtenstein},
  journal={Archives of general psychiatry},
  year={1999},
  volume={56 1},
  pages={29-36}
}
BACKGROUND Disturbances of N-methyl-D-aspartate (NMDA) receptor-mediated glutamatergic neurotransmission may play an important role in the pathophysiology of negative symptoms of schizophrenia. Glycine, a small nonessential amino acid, functions as an obligatory coagonist at NMDA receptors through its action at a strychnine-insensitive binding site on the NMDA receptor complex. Glycine-induced augmentation of NMDA receptor-mediated neurotransmission may thus offer a potentially safe and… CONTINUE READING
Highly Influential
This paper has highly influenced 15 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 145 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 47 references

Ameliora- ARCH GEN PSYCHIATRY

  • DC Javitt, I Zylberman, SR Zukin, U Heresco-Levy, J. Lindenmayer
  • JAN
  • 1999

Drugs and the treatment of psychiatric disorders: antipsy- chotic and antianxiety agents

  • RJ Baldessarini
  • eds. Goodman and Gilman’s the Pharmacologic Basis…
  • 1996

Similar Papers

Loading similar papers…